Detumomab
Detumomab
Detumomab (pronunciation: deh-too-moh-mab) is a type of monoclonal antibody used in cancer treatment. It is designed to target and bind to specific proteins on the surface of cancer cells, thereby helping the immune system to recognize and destroy those cells.
Etymology
The term "Detumomab" is derived from the Latin detumo, meaning "I swell", and mab, an abbreviation for monoclonal antibody. This reflects the drug's function in targeting swollen, or abnormal, cells in the body.
Usage
Detumomab is used in the treatment of various types of cancer, including breast cancer, lung cancer, and colorectal cancer. It works by binding to specific proteins on the surface of cancer cells, thereby marking them for destruction by the body's immune system.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells. Detumomab is a type of monoclonal antibody.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Detumomab is used in the treatment of various types of cancer.
- Immunotherapy: A type of cancer treatment that helps your immune system fight cancer. Detumomab is a form of immunotherapy.
See Also
External links
- Medical encyclopedia article on Detumomab
- Wikipedia's article - Detumomab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski